Landscape Capital Management L.L.C. Trims Holdings in Cardinal Health, Inc. $CAH

Key Points

• Landscape Capital Management reduced its holdings in Cardinal Health by 24.4%, selling 3,177 shares, and currently possesses 9,819 shares valued at approximately $1.35 million.
• Cardinal Health recently announced a quarterly dividend of $0.5107, which will be paid on October 15th, with a current dividend yield of 1.4%.
• CEO Jason M. Hollar sold 107,705 shares for over $16 million, resulting in a 31.35% decrease in his ownership in the company.

Landscape Capital Management L.L.C. trimmed its holdings in shares of Cardinal Health, Inc. (NYSE:CAH - Free Report) by 24.4% during the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 9,819 shares of the company's stock after selling 3,177 shares during the period. Landscape Capital Management L.L.C.'s holdings in Cardinal Health were worth $1,353,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other large investors have also modified their holdings of CAH. Integrated Wealth Concepts LLC increased its holdings in Cardinal Health by 22.4% during the fourth quarter. Integrated Wealth Concepts LLC now owns 4,083 shares of the company's stock valued at $483,000 after buying an additional 748 shares during the period. Rehmann Capital Advisory Group boosted its holdings in shares of Cardinal Health by 8.2% in the 4th quarter. Rehmann Capital Advisory Group now owns 2,946 shares of the company's stock valued at $348,000 after buying an additional 223 shares in the last quarter. Itau Unibanco Holding S.A. bought a new position in shares of Cardinal Health during the 4th quarter worth approximately $36,000. Wahed Invest LLC lifted its position in Cardinal Health by 6.4% during the fourth quarter. Wahed Invest LLC now owns 6,292 shares of the company's stock valued at $741,000 after acquiring an additional 378 shares during the last quarter. Finally, AXA S.A. boosted its stake in Cardinal Health by 47.8% in the fourth quarter. AXA S.A. now owns 535,739 shares of the company's stock valued at $63,362,000 after acquiring an additional 173,250 shares in the last quarter. Institutional investors own 87.17% of the company's stock.

Insider Buying and Selling

In related news, insider Michelle D. Greene sold 13,500 shares of the company's stock in a transaction that occurred on Tuesday, August 19th. The stock was sold at an average price of $148.82, for a total value of $2,009,070.00. Following the transaction, the insider directly owned 14,976 shares in the company, valued at approximately $2,228,728.32. This represents a 47.41% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Also, CEO Stephen M. Mason sold 41,575 shares of the stock in a transaction that occurred on Tuesday, August 19th. The stock was sold at an average price of $148.82, for a total value of $6,187,191.50. Following the completion of the transaction, the chief executive officer owned 26,085 shares of the company's stock, valued at $3,881,969.70. The trade was a 61.45% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 271,676 shares of company stock worth $40,489,525 over the last ninety days. 0.09% of the stock is currently owned by insiders.

Analyst Upgrades and Downgrades

A number of analysts have recently weighed in on the company. Wells Fargo & Company reissued an "overweight" rating and issued a $185.00 price objective (up previously from $183.00) on shares of Cardinal Health in a research report on Wednesday, August 13th. Evercore ISI reduced their target price on shares of Cardinal Health from $200.00 to $190.00 and set an "outperform" rating for the company in a report on Wednesday, August 13th. UBS Group restated a "buy" rating on shares of Cardinal Health in a research report on Tuesday, August 12th. Robert W. Baird raised their target price on Cardinal Health from $197.00 to $203.00 and gave the company an "outperform" rating in a research report on Wednesday, August 13th. Finally, Bank of America increased their price target on Cardinal Health from $165.00 to $170.00 and gave the stock a "buy" rating in a research report on Tuesday, June 10th. Twelve research analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the stock. According to MarketBeat, the stock currently has an average rating of "Moderate Buy" and an average target price of $165.93.

Cardinal Health Stock Performance

Shares of CAH traded up $0.89 during trading hours on Wednesday, hitting $150.44. 839,930 shares of the stock were exchanged, compared to its average volume of 2,416,364. The stock's 50-day moving average price is $156.81 and its two-hundred day moving average price is $146.48. Cardinal Health, Inc. has a 12-month low of $106.54 and a 12-month high of $168.44. The company has a market cap of $35.92 billion, a price-to-earnings ratio of 23.32, a price-to-earnings-growth ratio of 1.26 and a beta of 0.73.

Cardinal Health (NYSE:CAH - Get Free Report) last released its quarterly earnings data on Tuesday, August 12th. The company reported $2.08 EPS for the quarter, beating analysts' consensus estimates of $2.03 by $0.05. Cardinal Health had a net margin of 0.70% and a negative return on equity of 74.45%. The company had revenue of $60.16 billion during the quarter, compared to the consensus estimate of $60.91 billion. During the same quarter in the prior year, the firm earned $1.84 EPS. Cardinal Health's quarterly revenue was up .5% on a year-over-year basis. Cardinal Health has set its FY 2026 guidance at 9.300-9.500 EPS. On average, research analysts expect that Cardinal Health, Inc. will post 7.95 earnings per share for the current year.

Cardinal Health Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Wednesday, October 15th. Shareholders of record on Wednesday, October 1st will be paid a dividend of $0.5107 per share. The ex-dividend date of this dividend is Wednesday, October 1st. This represents a $2.04 dividend on an annualized basis and a yield of 1.4%. Cardinal Health's payout ratio is 31.63%.

About Cardinal Health

Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.